Torchilin VP - Search Results

1

P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells.

Navarro G, Sawant RR, Biswas S, Essex S, Tros de Ilarduya C, Torchilin VP. Navarro G, et al. Among authors: torchilin vp. Nanomedicine (Lond). 2012 Jan;7(1):65-78. doi: 10.2217/nnm.11.93. Nanomedicine (Lond). 2012. PMID: 22191778 Free PMC article.

2

Multifunctionality of lipid-core micelles for drug delivery and tumour targeting.

Sawant RR, Torchilin VP. Sawant RR, et al. Among authors: torchilin vp. Mol Membr Biol. 2010 Oct;27(7):232-46. doi: 10.3109/09687688.2010.516276. Epub 2010 Oct 7. Mol Membr Biol. 2010. PMID: 20929339 Free article. Review.

3

Challenges in development of targeted liposomal therapeutics.

Sawant RR, Torchilin VP. Sawant RR, et al. Among authors: torchilin vp. AAPS J. 2012 Jun;14(2):303-15. doi: 10.1208/s12248-012-9330-0. Epub 2012 Mar 14. AAPS J. 2012. PMID: 22415612 Free PMC article. Review.

4

Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery.

Biswas S, Deshpande PP, Navarro G, Dodwadkar NS, Torchilin VP. Biswas S, et al. Among authors: torchilin vp. Biomaterials. 2013 Jan;34(4):1289-301. doi: 10.1016/j.biomaterials.2012.10.024. Epub 2012 Nov 5. Biomaterials. 2013. PMID: 23137395 Free PMC article.

5

Current trends in the use of liposomes for tumor targeting.

Deshpande PP, Biswas S, Torchilin VP. Deshpande PP, et al. Among authors: torchilin vp. Nanomedicine (Lond). 2013 Sep;8(9):1509-28. doi: 10.2217/nnm.13.118. Nanomedicine (Lond). 2013. PMID: 23914966 Free PMC article. Review.

6

Phospholipid-modified polyethylenimine-based nanopreparations for siRNA-mediated gene silencing: implications for transfection and the role of lipid components.

Navarro G, Essex S, Sawant RR, Biswas S, Nagesha D, Sridhar S, de ILarduya CT, Torchilin VP. Navarro G, et al. Among authors: torchilin vp. Nanomedicine. 2014 Feb;10(2):411-9. doi: 10.1016/j.nano.2013.07.016. Epub 2013 Aug 6. Nanomedicine. 2014. PMID: 23928214 Free PMC article.

7

Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors.

Essex S, Navarro G, Sabhachandani P, Chordia A, Trivedi M, Movassaghian S, Torchilin VP. Essex S, et al. Among authors: torchilin vp. Gene Ther. 2015 Mar;22(3):257-266. doi: 10.1038/gt.2014.97. Epub 2014 Oct 30. Gene Ther. 2015. PMID: 25354685 Free PMC article.

8

Micelle-like nanoparticles as carriers for DNA and siRNA.

Navarro G, Pan J, Torchilin VP. Navarro G, et al. Among authors: torchilin vp. Mol Pharm. 2015 Feb 2;12(2):301-13. doi: 10.1021/mp5007213. Epub 2015 Jan 12. Mol Pharm. 2015. PMID: 25557580 Free PMC article. Review.

9

Design, synthesis, and initial biological evaluation of a steroidal anti-estrogen-doxorubicin bioconjugate for targeting estrogen receptor-positive breast cancer cells.

Dao KL, Sawant RR, Hendricks JA, Ronga V, Torchilin VP, Hanson RN. Dao KL, et al. Among authors: torchilin vp. Bioconjug Chem. 2012 Apr 18;23(4):785-95. doi: 10.1021/bc200645n. Epub 2012 Apr 4. Bioconjug Chem. 2012. PMID: 22404783 Free PMC article.

10

Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer.

Salzano G, Riehle R, Navarro G, Perche F, De Rosa G, Torchilin VP. Salzano G, et al. Among authors: torchilin vp. Cancer Lett. 2014 Feb 28;343(2):224-31. doi: 10.1016/j.canlet.2013.09.037. Epub 2013 Oct 4. Cancer Lett. 2014. PMID: 24099916 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

532 results

Search Page

Filters